A Challenging Diagnosis of Merkel Cell Carcinoma Occurring in the Lymph Nodes and Skin of a Patient with Mantle Cell Lymphoma: A Case Report
DOI:
https://doi.org/10.2340/actadv.v103.12328Keywords:
Merkel cell carcinoma, Mantle cell lymphoma, skin cancerAbstract
Abstract is missing (Short communication)
Downloads
References
Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peñas P, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the "AEIOU" features. J Am Acad Dermatol 2008; 58: 375-381.
https://doi.org/10.1016/j.jaad.2007.11.020 DOI: https://doi.org/10.1016/j.jaad.2007.11.020
Jacobs D, Huang H, Olino K, Weiss S, Kluger H, Judson BL, et al. Assessment of age, period, and birth cohort effects and trends in merkel cell carcinoma incidence in the United States. JAMA Dermatol 2021; 157: 59-65.
https://doi.org/10.1001/jamadermatol.2020.4102 DOI: https://doi.org/10.1001/jamadermatol.2020.4102
McEvoy AM, Lachance K, Hippe DS, Cahill K, Moshiri Y, Lewis CW, et al. Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis. JAMA Dermatol 2022; 158: 382-389.
https://doi.org/10.1001/jamadermatol.2021.6096 DOI: https://doi.org/10.1001/jamadermatol.2021.6096
Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol 2017; 92: 806-813.
https://doi.org/10.1002/ajh.24797 DOI: https://doi.org/10.1002/ajh.24797
Sen F, Medeiros LJ, Lu D, Jones D, Lai R, Katz R, et al. Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features. Am J Surg Pathol 2002; 26: 1312-1318.
https://doi.org/10.1097/00000478-200210000-00008 DOI: https://doi.org/10.1097/00000478-200210000-00008
Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 1545-1549.
https://doi.org/10.1158/1055-9965.EPI-05-0895 DOI: https://doi.org/10.1158/1055-9965.EPI-05-0895
Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010; 102: 793-801.
https://doi.org/10.1093/jnci/djq120 DOI: https://doi.org/10.1093/jnci/djq120
Brewer JD, Shanafelt TD, Otley CC, Roenigk RK, Cerhan JR, Kay NE, et al. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. J Clin Oncol 2012; 30: 843-849.
https://doi.org/10.1200/JCO.2011.34.9605 DOI: https://doi.org/10.1200/JCO.2011.34.9605
Katerji R, Yigit N, Lozeau D, Liu Y, Tam W, Crane GM. Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls. Ann Diagn Pathol 2022; 56: 151868.
https://doi.org/10.1016/j.anndiagpath.2021.151868 DOI: https://doi.org/10.1016/j.anndiagpath.2021.151868
Hoang MP, Donizy P, Wu CL, Kopczynski J, Pieniazek M, Miller DM, et al. TdT Expression is a marker of better survival in Merkel cell carcinoma, and expression of B-cell markers is associated with Merkel cell polyomavirus. Am J Clin Pathol 2020; 154: 38-47.
https://doi.org/10.1093/ajcp/aqaa017 DOI: https://doi.org/10.1093/ajcp/aqaa017
Robak E, Biernat W, Krykowski E, Jeziorski A, Robak T. Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab. Leuk Lymphoma 2005; 46: 909-914.
https://doi.org/10.1080/10428190500057759 DOI: https://doi.org/10.1080/10428190500057759
Antonios B, Karki U, Antonios K, Ghimire B, Chisti MM. Development of Merkel cell carcinoma in a patient receiving rituximab. Case Rep Oncol Med 2022; 2022: e1814338.
https://doi.org/10.1155/2022/1814338 DOI: https://doi.org/10.1155/2022/1814338
Cohen Y, Amir G, Polliack A. Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma. Eur J Haematol 2002; 68: 117-119.
https://doi.org/10.1034/j.1600-0609.2002.01600.x DOI: https://doi.org/10.1034/j.1600-0609.2002.01600.x
Wirges ML, Saporito F, Smith J. Rapid growth of Merkel cell carcinoma after treatment with rituximab. J Drugs Dermatol 2006; 5: 180-181.
Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, et al. Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. J Immunother Cancer 2020; 8: e000897.
https://doi.org/10.1136/jitc-2020-000897 DOI: https://doi.org/10.1136/jitc-2020-000897
Published
How to Cite
License
Copyright (c) 2023 Emily Y. Kim, Ann W. Silk, Mia S. DeSimone, Elizabeth A. Morgan, Manisha Thakuria
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
